NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX)

CUSIP: 64125C109

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
99,963,154
Total 13F shares
93,842,806
Share change
-2,009,549
Total reported value
$7,281,125,612
Put/Call ratio
122%
Price per share
$77.59
Number of holders
260
Value change
-$128,562,595
Number of buys
136
Number of sells
113

Quarterly Holders Quick Answers

What is CUSIP 64125C109?
CUSIP 64125C109 identifies NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) as of Q4 2017

As of 31 Dec 2017, NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) was held by 260 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 93,842,806 shares. The largest 10 holders included FMR LLC, Vanguard Group Inc, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., BB BIOTECH AG, WELLINGTON MANAGEMENT GROUP LLP, FRANKLIN RESOURCES INC, and Invesco Ltd.. This page lists 260 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.